1. Background {#sec1}
=============

Compound Kushen Injection (CKI), is a pure TCM extracted from two herbs,*Radix Sophorae Flavescentis* and*Rhizoma Hterosmilacis*. In TCM theory, CKI has the effect of clearing heat, promoting diuresis, removing pathogenic and toxic material from the body \[[@B1]\]. With the effective components of oxymatrine, oxysophocarpine, and matrine \[[@B2]\], it has been widely applied into treatment of various kinds of malignant tumors in China, including colon carcinoma (CC) \[[@B3]\]. CKI has been listed in the Drug Directory for National Medical Insurance, Employment Injury Insurance, and Maternity Insurance \[[@B4]\]. It is also listed as therapeutic medication for CC according to Guideline for Diagnosis and Treatment of Tumor in TCM \[[@B5]\] published by China Association of Chinese Medicine in 2008 and Clinical Practice Guidelines of Chinese Medicine in Oncology \[[@B6]\] issued by China Academy of Chinese Medical Sciences in 2014.

Trails have showed that CKI can improve overall efficiency of the treatment for multiple malignant tumors, relieve clinical symptoms such as cancer pain, fever, and fatigue, and potentiate the efficacy of chemotherapy and radiotherapy for CC with additional toxicity reduction effect \[[@B3], [@B8], [@B9]\]. The mechanisms of CKI comprise inhibiting the proliferation and metastasis of tumor cells \[[@B10]--[@B12]\], inducing the differentiation and apoptosis of tumor cells \[[@B13], [@B14]\], restraining the formation of tumor neovascularization \[[@B15]\], suppressing tumors\' drug resistance \[[@B16]\], and inducing the autophagy of tumor cells \[[@B17], [@B18]\]. Previous studies show that compared with pure chemotherapy treatment, CKI combined with chemotherapy can improve clinical effects and patients\' life quality, extend lifetime, and reduce the toxicity of chemotherapy \[[@B19]--[@B21]\]. The mechanism of which includes improving the immunity of patients with CC \[[@B22]\], restraining the proliferation of colon cancer cells and inducing their apoptosis \[[@B23], [@B24]\], suppressing the formation of tumor neovascularization \[[@B25]\], and curbing the activation of NF-*κ*B inside macrophage \[[@B26]\].

Real-world studies (RWS) include a spectrum of studies that apply various methods to data collected from real world settings \[[@B27]\]. Real world evidence is important for informing healthcare practice and developing medical products and has gained broad interest in healthcare \[[@B28]\]. In China, the term "real world evidence" was not explicitly used until 2010, when researchers from our group in Institute of Basic Research in Clinical Medicine (IBRCM), China Academy of Traditional Chinese Medical Sciences (CACMS), carried out the first RWS to evaluate traditional Chinese medicine interventions \[[@B29]\]. Retrospective studies using electrical medical record (EMR) collected from hospital information system (HIS) are one of the most important categories of RWS \[[@B28]\] and are important for postapproval drug assessment \[[@B30]\], healthcare quality improvement \[[@B31]\], and new indications of medical products \[[@B32]\].

EMR stored in HIS have inherent strengths of high reliability of sources, large scale of samples, accuracy of recording, reasonable framework, and abundance in dimensions. Particularly, it records detailed medication orders throughout the whole treatment process at the time of hospitalization \[[@B33]\]. The laws of combined medication can thus be found through the large quantity of data provided by HIS. Considering CKI has been widely applied into treatment of CC in China, our present study aimed to validate the interrelationships of combined medication of CKI in the treatment of CC by using HIS EMR and thus provide evidence for rational use of CKI in real world settings.

2. Methods {#sec2}
==========

2.1. Data Sources {#sec2.1}
-----------------

This study was conducted based on a large-scale integrated data warehouse of EMR from HIS of 39 Class A tertiary hospitals in China, that was built by IBRCM of CACMS \[[@B27], [@B34], [@B35]\]. EMR of patients whose first-listed diagnoses were CC and were treated with CKI were extracted from 22 hospitals among the above-mentioned medical centers.

2.2. Standardization of Database Structure {#sec2.2}
------------------------------------------

Due to the difference in data structure of HIS of varied hospitals, IBRCM, by standardizing original data structure, built an integrated database with the same structure of variables that contained general information, diagnosis information, medication orders, and laboratory test results. Patient\'s ID is the only index that links different data subsets.

2.3. Data Standardization {#sec2.3}
-------------------------

All analyses were made on account of standardized modern medicine diagnosis information and medication orders. Disease names were standardized with reference to ICD-10 \[[@B36]\]. Chinese patent medicines with the same ingredients but in different drug forms were standardized and merged, while their TCM theory based pharmacological mechanisms were classified in accordance with their major functions. Modern medicines were standardized by translating their trade name into chemical name (if applicable), and their pharmacological effects were normalized and categorized with reference to*Pharmacopoeia of the People\'s Republic of China* (2010) \[[@B37]\].

2.4. Exclusion Criteria {#sec2.4}
-----------------------

Exclusion criteria of combined medicines are as follows: (1) solvents, including glucose injection, sodium chloride injection, and glucose and sodium chloride injection, were excluded; (2) potassium chloride and vitamins (except for Vitamin C) were excluded; (3) insulin when combined with glucose injection or glucose and sodium chloride injection was excluded; (4) heparin only when administrated through intravenous drip, intravenous injection, pumping, or subcutaneous injection was excluded; (5) combined drugs the medication administration time of which did not fall into that of CKI were excluded.

2.5. Data Analysis {#sec2.5}
------------------

Descriptive statistical analyses in this study were carried out using SAS software*(version 9.3, SAS Institute Inc., Cary, NC, U.S.A).*Considering the complexity of drug combination, only the medicines that have been frequently used in conjunction with CKI (top 20 excerpted) were included for data mining analyses. Apriori algorithm based association rule analysis (ARA) and plotting in this study were processed by SPSS Clementine software*(version 12.0, SPSS Inc., Chicago, IL, U.S.A)*.

3. Results {#sec3}
==========

3.1. Characteristics of General Information {#sec3.1}
-------------------------------------------

EMR of 3328 patients first diagnosed with CC among 49597 patients who were treated with CKI at the time of hospitalization were included in the study. The earliest record of case was August 2002, while the latest one was December 2014. The characteristics are as follows: gender: male: 1953 cases, female: 1353 cases, and missing: 22 cases; age: 61.85±13.68 years old; length of hospital stays: 11.96±6.43 days; course of CKI treatment: 9.32±6.28 days; single dosage of CKI: 16.73±5.63 ml; daily dosage of CKI: 15.84±4.17 ml.

3.2. Distribution Characteristics of Combined TCMs {#sec3.2}
--------------------------------------------------

227 traditional Chinese medicines were used in conjunction with CKI. Top 20 were tabulated based on the frequency of use ([Table 1](#tab1){ref-type="table"}).

3.3. Distribution Characteristics of Combined Modern Medicines {#sec3.3}
--------------------------------------------------------------

760 modern medicines were used in conjunction with CKI. Top 20 were tabulated based on the frequency of use ([Table 2](#tab2){ref-type="table"}).

3.4. TCM Pharmacological Mechanism Distribution Characteristics of Combined TCMs {#sec3.4}
--------------------------------------------------------------------------------

Frequency order of pharmacological mechanism of combined TCMs (top 20) is shown in [Table 3](#tab3){ref-type="table"}.

3.5. Pharmacological Mechanism Distribution Characteristics of Combined Modern Medicines {#sec3.5}
----------------------------------------------------------------------------------------

Frequency order of pharmacological mechanism of combined modern medicines (top 20) is shown in [Table 4](#tab4){ref-type="table"}.

3.6. ARA of Combined TCMs {#sec3.6}
-------------------------

TCMs are used in conjunction with CKI. The association rules between different medicines obtained by ARA are ordered by Support. Top 10 are listed in [Table 5](#tab5){ref-type="table"}. The features are visually presented based on network of associations in [Figure 1](#fig1){ref-type="fig"}.

In [Figure 1](#fig1){ref-type="fig"}, in order to show the difference of correlation between combined drugs, use frequency≧1.06% is represented by bold line; use frequency≦0.5% is represented by dotted line; use frequency between 0.5% and 1.06% is represented by fine line.

3.7. ARA of Combined Modern Medicines and Merged Analysis {#sec3.7}
---------------------------------------------------------

Modern medicines are used in conjunction with CKI. The association rules between different medicines obtained by ARA are ordered by Support. Top 10 are listed in [Table 6](#tab6){ref-type="table"}. The features are visually presented based on network of associations in [Figure 2](#fig2){ref-type="fig"}. In merged analysis, the network of associations is shown in [Figure 3](#fig3){ref-type="fig"}.

In [Figure 2](#fig2){ref-type="fig"}, use frequency≧20.3% is represented by bold line; use frequency≦12% is represented by dotted line; use frequency between 12% and 20.3% is represented by fine line.

In [Figure 3](#fig3){ref-type="fig"}, use frequency≧7.49% is represented by bold line; use frequency≦2.87% is represented by dotted line; use frequency between 2.87% and 7.49% is represented by fine line.

3.8. ARA of Pharmacological Mechanisms of Combined TCMs {#sec3.8}
-------------------------------------------------------

The association rules between different pharmacological mechanisms of combined TCMs obtained by ARA are ordered by Support. Top 10 are listed in [Table 7](#tab7){ref-type="table"}. The features are visually presented based on network of associations in [Figure 4](#fig4){ref-type="fig"}.

In [Figure 4](#fig4){ref-type="fig"}, in order to show the difference of correlation of pharmacological mechanism between combined drugs, use frequency≧2.08% is represented by bold line; use frequency≦0.42% is represented by dotted line; use frequency between 0.42% and 2.08% is represented by fine line.

3.9. ARA of Pharmacological Mechanism of Combined Modern Medicines, and Merged Analysis {#sec3.9}
---------------------------------------------------------------------------------------

Modern medicines are used in conjunction with CKI. The association rules between different pharmacological mechanisms of combined modern medicines obtained by ARA are ordered by Support. Top 10 are listed in [Table 8](#tab8){ref-type="table"}. The features are visually presented based on network of associations in [Figure 5](#fig5){ref-type="fig"}. In merged analysis, the network of associations is shown in [Figure 6](#fig6){ref-type="fig"}.

In [Figure 5](#fig5){ref-type="fig"}, use frequency≧30.4% is represented by bold line; use frequency≦17.4% is represented by dotted line; use frequency between 17.4% and 30.4% is represented by fine line.

In [Figure 6](#fig6){ref-type="fig"}, use frequency≧28.1% is represented by bold line; use frequency≦5.15% is represented by dotted line; use frequency between 5.15% and 28.1% is represented by fine line.

4. Discussion {#sec4}
=============

ARA is widely used to analyze internal connections hidden in item sets of multidimensional data \[[@B38]--[@B40]\]. In this study, ARA is performed to generate candidate item sets under a threshold control of support and confidence and finally identify association rules that highlight general trends in the database of combined TCMs and modern medicines. Association rules are presented in the implicative expression of A =\> B. Support (A -\> B) = P (A U B). Support equals the probability of coadministration of drugs A and B. It is used to assess the frequency and importance of association rules. Confidence (A -\> B) = P (A∣B). Confidence equals the probability of administration of drug B after drug A is used. It is capable of assessing the intensity and reliability of association rules \[[@B41]\].

In terms of features of combination with other TCMs, CKI is most often administrated in conjunction with TCMs with the pharmacological mechanisms of qi-reinforcing, heat-clearing and detoxifying, blood circulation-promoting and stasis-removing, spleen-invigorating and stomach-harmonizing, and qi-regulating. The common combinations include the following: (1) on the basis of combination of CKI and qi-reinforcing, using one of the following: heat-clearing and detoxifying, blood circulation-promoting and stasis-removing, blood-stanching, bowel-relaxing, qi-regulating, spleen-invigorating and stomach-harmonizing, and blood-regulating; (2) on the basis of combination of CKI and heat-clearing and detoxifying, using one of the following: blood circulation-promoting and stasis-removing, blood-stanching, bowel-relaxing, qi-regulating, spleen-invigorating and stomach-harmonizing, blood-regulating, swelling-reducing and mass-resolving, for yin-tonifying, for reviving yang to save from collapse, qi-reinforcing and blood-nourishing; (3) on the basis of combination of CKI and blood circulation-promoting and stasis-removing, using blood-stanching and qi-regulating; (4) on the basis of combination of CKI and qi-regulating, using bowel-relaxing used. In TCM theory, a number of pathogenic factors cause the malfunction of large intestine and stagnant movement of qi, blood, and body fluid, leading to certain pathological changes such as stagnation of qi and blood, phlegm stasis, damp turbidity, and heat-toxicity. Stagnated in large intestine, these pathological products interact with each other and eventually form tangible lumps as time goes by. The above combinations of TCMs when treating CC have effects of reinforcing healthy qi, clearing heat and detoxication, reinforcing qi and invigorating spleen, eliminating dampness and regulating the stomach, regulating qi and relieving pain, smoothing qi, and removing stasis. They are in line with*Guideline for Diagnosis and Treatment of Tumor in TCM*published by China Association of Chinese Medicine \[[@B5]\].

In terms of features of combination with modern medicines, CKI is most often administrated in conjunction with antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids. The common combinations include the following: (1) on the basis of combination of CKI and antineoplastic chemotherapeutic drugs, using one of the following drugs: immunomodulator, 5-HT receptor antagonist drugs, antibiotics, antifolate, nutritious drugs, corticosteroids, hepatic protector, proton pump inhibitor, dopamine receptor antagonist; (2) on the basis of combination of CKI and immunomodulator, using one of the following drugs: 5-HT receptor antagonist drugs, antibiotics, nutritious drugs, hepatic protector, proton pump inhibitor; (3) on the basis of combination of CKI and antibiotics, using nutritious drugs; (4) on the basis of combination of CKI and corticosteroids, using antifolate, dopamine receptor antagonist, and antineoplastic drugs; (5) CKI being administrated in conjunction with antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids. According to guidelines \[[@B46]--[@B48]\], major therapeutic strategy to treat CC includes chemotherapy before operation and administration of antibiotics, immunomodulator, and corticosteroids after operation. Antineoplastic chemotherapeutic drugs, antibiotics, and immunomodulator are strongly recommended with a view to raising total survival rate, preventing postoperative infection, prolonging survival period for recurrent patients, and improving life quality. The above combinations have effects of inhibiting the proliferation of CC cells, preventing infection, alleviating the side effect of radiotherapy and chemotherapy, and mitigating local compression and edema. They are confronted with clinical guidelines for diagnosis and treatment of CC \[[@B47], [@B49], [@B50]\].

In merged analysis, the common combinations include the following: (1) on the basis of combination of CKI and heat-clearing and detoxifying, antineoplastic chemotherapeutic drugs and immunomodulator are used at the same time; (2) on the basis of combination of CKI and qi-reinforcing, antineoplastic chemotherapeutic drugs are used; (3) on the basis of combination of CKI and antibiotics, antineoplastic chemotherapeutic drugs, and immunomodulator are used at the same time; (4) on the basis of combination of CKI and antineoplastic chemotherapeutic drugs, 5-HT receptor antagonist drugs, and corticosteroids are used, respectively; (5) on the basis of combination of CKI and 5-HT receptor antagonist drugs, corticosteroids are used; (6) on the basis of combination of CKI and immunomodulator, either antineoplastic chemotherapeutic drugs, 5-HT receptor antagonist drugs, or corticosteroids is added. The combination of TCM and chemotherapeutics has been proved to have the effect of relieving symptoms, raising life quality, strengthening immune functions, and alleviating the side effect of chemotherapy when treating CC \[[@B19], [@B43], [@B45]\].

Strengths of our present study should be noted. (1) The data source of this study is of high quality. The large-scale integrated data warehouse records EMR of over three million cases from HIS of 39 Class A tertiary hospitals nationwide in China. It covers demographic data, diagnosis information of TCM and modern medicine, medication orders, common clinical test results, and treatment outcomes \[[@B34], [@B35]\]. (2) Standardization of database structure, standardization of different categories of variables, and strict logic checking were performed before analysis to ensure quality control. (3) The advantages of ARA include good adaptability for analysis of multidimensional and nonlinear medication and disease related variables \[[@B51]\].

Disadvantages of this study should also be addressed. (1) HIS EMR is derived from real-world records in the process of clinical treatment and is not originally designed for research purposes. (2) Selection bias may exist because data were derived from participants in 22 hospitals in China, and therefore the cases are likely not representative of patients in other medical centers nationwide. (3) Apriori algorithm generates a large quantity of candidate sets in the ARA procedure by repeatedly scanning all the records in database. Hence, such large amount of calculation by apriori algorithm may consume too many resources when it comes to the analysis of large-scale database.

5. Conclusion {#sec5}
=============

CKI has been used extensively integrated with both modern medicines and TCMs when treating CC in China. The pharmacological mechanisms of TCMs that most frequently combined with CKI include heat-clearing and detoxifying, qi-reinforcing, blood circulation-promoting and stasis-removing, blood-stanching, and qi-regulating. For modern medicines, antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids are most often combined with CKI. The associations of medication combinations of CKI in treating CC in real world manifest certain laws for both TCMs and modern medicines. Further explorations are needed to verify and expand the conclusions.
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###### 

Frequency of TCMs combined with CKI (Top 20, N=3328).

  Frequency sequence   Medication                 Distribution frequency (%)   Frequency sequence   Medication                    Distribution frequency (%)
  -------------------- -------------------------- ---------------------------- -------------------- ----------------------------- ----------------------------
  1                    Yadanzi Youru injection    443 (13.31)                  11                   Lianqi capsules               110 (3.31)
  2                    Zhenqi Fuzheng granules    345 (10.37)                  12                   Kangfuxin liquid              109 (3.28)
  3                    Shenqi Fuzheng injection   317 (9.53)                   13                   Shengmai injection            91 (2.73)
  4                    Aidi injection             297 (8.92)                   14                   Tongbianling capsules         84 (2.52)
  5                    Ganmao Qingre granules     295 (8.86)                   15                   Qirong Runchang oral liquid   78 (2.34)
  6                    Yunnan Baiyao capsules     261 (7.84)                   16                   Tanreqing injection           77 (2.31)
  7                    Simotang oral liquid       214 (6.43)                   17                   Shengmai II oral liquid       74 (2.22)
  8                    Kangai injection           182 (5.47)                   18                   Shenfu injection              73 (2.19)
  9                    Xiaoaiping injection       170 (5.11)                   19                   Qingkailing injection         71 (2.13)
  10                   Jianpi Yishen granules     138 (4.15)                   20                   Xihuang capsules              69 (2.07)

###### 

Frequency of modern medicines combined with CKI (Top 20, N=3328).

  Frequency sequence   Medication                            Distribution frequency (%)   Frequency sequence   Medication                        Distribution frequency (%)
  -------------------- ------------------------------------- ---------------------------- -------------------- --------------------------------- ----------------------------
  1                    Tropisetron                           1599 (48.05)                 11                   Ornidazole                        660 (19.83)
  2                    Thymosin                              1554 (46.69)                 12                   Lidocaine                         651 (19.56)
  3                    Oxaliplatin                           1509 (45.34)                 13                   Recombinant human Interleukin 2   636 (19.11)
  4                    Fluorouracil                          1361 (40.90)                 14                   Reduced glutathione               629 (18.90)
  5                    Leucovorin                            1271 (38.19)                 15                   Alanyl-glutamine                  623 (18.72)
  6                    Dexamethasone                         1250 (37.56)                 16                   Furosemide                        590 (17.73)
  7                    Metoclopramide                        1018 (30.59)                 17                   Cinobufagin                       569 (17.10)
  8                    Amino acid                            964 (28.97)                  18                   Ambroxol                          550 (16.53)
  9                    Medium- and long-chain fat emulsion   794 (23.86)                  19                   Omeprazole                        550 (16.53)
  10                   Pantoprazole sodium                   794 (23.86)                  20                   Human serum albumin               527 (15.84)

###### 

Frequency of TCM pharmacological mechanisms of TCMs combined with CKI (Top 20, N=3328).

  Frequency sequence   TCM Pharmacological mechanism                     Distribution frequency (%)   Frequency sequence   TCM Pharmacological mechanism                           Distribution frequency (%)
  -------------------- ------------------------------------------------- ---------------------------- -------------------- ------------------------------------------------------- ----------------------------
  1                    Heat-clearing and detoxifying                     1535 (46.12)                 11                   Reviving yang to save from collapse                     73 (2.19)
  2                    Qi-reinforcing                                    1159 (34.83)                 12                   Qi-reinforcing and blood-nourishing                     52 (1.56)
  3                    Blood circulation-promoting and stasis-removing   312 (9.38)                   13                   Warming interior                                        49 (1.47)
  4                    Blood-stanching                                   294 (8.83)                   14                   Promoting circulation of qi and blood to relieve pain   49 (1.47)
  5                    Qi-regulating                                     273 (8.20)                   15                   Cough-relieving                                         39 (1.17)
  6                    Bowel-relaxing                                    260 (7.81)                   16                   Cough-preventing                                        33 (0.99)
  7                    Spleen-invigorating and stomach-harmonizing       163 (4.90)                   17                   Digestion-promoting                                     32 (0.96)
  8                    Swelling-reducing and mass-resolving              103 (3.09)                   18                   Phlegm-eliminating                                      31 (0.93)
  9                    Blood-regulating                                  94 (2.82)                    19                   Blood-nourishing and tranquilization                    25 (0.75)
  10                   Yin-tonifying                                     75 (2.25)                    20                   Yang-tonifying                                          23 (0.69)

###### 

Frequency of pharmacological mechanisms of modern medicines combined with CKI (Top 20, N=3328).

  Frequency sequence   Pharmacological mechanism               Distribution frequency (%)   Frequency sequence   Pharmacological mechanism                     Distribution frequency (%)
  -------------------- --------------------------------------- ---------------------------- -------------------- --------------------------------------------- ----------------------------
  1                    Antineoplastic chemotherapeutic drugs   2760 (82.93)                 11                   Painkiller                                    1030 (30.95)
  2                    Immunomodulator                         2308 (69.35)                 12                   Tranquilizer                                  947 (28.46)
  3                    Antibiotics                             1676 (50.36)                 13                   Medicine for electrolyte balance adjustment   851 (25.57)
  4                    5-HT receptor antagonist drugs          1658 (49.82)                 14                   Anesthetic                                    799 (24.01)
  5                    Nutritious drugs                        1386 (41.65)                 15                   Diuretics                                     786 (23.62)
  6                    Hepatic protector                       1303 (39.15)                 16                   H2 receptor antagonist drugs                  755 (22.69)
  7                    Proton pump inhibitor                   1243 (37.35)                 17                   Analgesic and anti-inflammatory drugs         668 (20.07)
  8                    Antifolate                              1211 (36.39)                 18                   Cell differentiation drugs                    607 (18.24)
  9                    Corticosteroids                         1152 (34.62)                 19                   Antianemics                                   603 (18.12)
  10                   Dopamine receptor antagonist            1063 (31.94)                 20                   Expectorant                                   557 (16.74)

###### 

Association rules of TCM combined with CKI.

  No.   Association rules                                    Support   Confidence
  ----- ---------------------------------------------------- --------- ------------
  1     Zhenqi Fuzheng granules =\>Ganmao Qingre granules    1.472     14.2
  2     Ganmao Qingre granules =\>Zhenqi Fuzheng granules    1.472     16.6
  3     Aidi injection =\>Yunnan Baiyao capsules             1.322     14.8
  4     Yunnan Baiyao capsules =\>Aidi injection             1.322     16.9
  5     Aidi injection =\>Yadanzi Youru injection            1.322     14.8
  6     Yunnan Baiyao capsules =\>Shenqi Fuzheng injection   1.292     16.5
  7     Ganmao Qingre granules =\>Yadanzi Youru injection    1.292     14.6
  8     Simotang oral liquid =\>Ganmao Qingre granules       1.262     19.6
  9     Ganmao Qingre granules =\>Simotang oral liquid       1.262     14.2
  10    Yunnan Baiyao capsules =\>Yadanzi Youru injection    1.262     16.1

###### 

Association rules of modern medicines combined with CKI.

  No.   Association rules             Support   Confidence
  ----- ----------------------------- --------- ------------
  1     Leucovorin =\>Oxaliplatin     33.4      87.3
  2     Oxaliplatin =\>Leucovorin     33.4      73.6
  3     Oxaliplatin =\>Tropisetron    30.3      66.8
  4     Tropisetron =\>Oxaliplatin    30.3      63.0
  5     Leucovorin =\>Fluorouracil    28.9      75.6
  6     Fluorouracil =\>Leucovorin    28.9      70.6
  7     Fluorouracil =\>Tropisetron   28.2      68.9
  8     Tropisetron =\>Fluorouracil   28.2      58.7
  9     Leucovorin =\>Tropisetron     27.7      72.5
  10    Tropisetron =\>Leucovorin     27.7      57.6

###### 

Association rules of pharmacological mechanism of TCMs combined with CKI.

  No.   Association rules                                                                  Support   Confidence
  ----- ---------------------------------------------------------------------------------- --------- ------------
  1     Qi-reinforcing =\>Heat-clearing and detoxifying                                    16.23     46.6
  2     Heat-clearing and detoxifying =\>Qi-reinforcing                                    16.23     35.2
  3     Blood circulation-promoting and stasis-removing=\>Heat-clearing and detoxifying    5.89      62.8
  4     Heat-clearing and detoxifying =\>Blood circulation-promoting and stasis-removing   5.89      12.8
  5     Blood-stanching =\>Heat-clearing and detoxifying                                   5.32      60.2
  6     Heat-clearing and detoxifying =\>Blood-stanching                                   5.32      11.5
  7     blood circulation-promoting and stasis-removing=\>Qi-reinforcing                   5.02      53.5
  8     Qi-reinforcing =\>Blood circulation-promoting and stasis-removing                  5.02      14.4
  9     Qi-regulating =\>Heat-clearing and detoxifying                                     4.78      58.2
  10    Heat-clearing and detoxifying =\>Qi-regulating                                     4.78      10.4

###### 

Association rules of pharmacological mechanisms of modern medicines combined with CKI.

  No.   Association rules                                                         Support   Confidence
  ----- ------------------------------------------------------------------------- --------- ------------
  1     Immunomodulator =\>Antineoplastic chemotherapeutic drugs                  57.8      83.4
  2     Antineoplastic chemotherapeutic drugs =\>Immunomodulator                  57.8      69.7
  3     5-HT receptor antagonist drugs =\>Antineoplastic chemotherapeutic drugs   48.1      96.6
  4     Antineoplastic chemotherapeutic drugs =\>5-HT receptor antagonist drugs   48.1      58.0
  5     Antibiotics =\>Antineoplastic chemotherapeutic drugs                      40.3      80.0
  6     Antineoplastic chemotherapeutic drugs =\>Antibiotics                      40.3      48.6
  7     5-HT receptor antagonist drugs =\>Immunomodulator                         37.5      75.3
  8     Immunomodulator =\>5-HT receptor antagonist drugs                         37.5      54.1
  9     Antibiotics =\>Immunomodulator                                            36.9      73.3
  10    Immunomodulator =\>Antibiotics                                            36.9      53.2

[^1]: Academic Editor: Massimo Nabissi
